Pharma fims line up investment for new manufacturing facilities in GujaratIllustrative image – not actual.

Gujarat government is set to attract fresh investment of around Rs 2,500–3,000 crore in pharmaceutical manufacturing after the state Food and Drugs Control Administration (FDCA) approved 59 new allopathic drug-making plants during 2025-26.

The upcoming facilities are expected to expand manufacturing capacity, strengthen compliance-led production and support higher-value exports from Gujarat’s established pharmaceutical clusters. Officials said several of the new plants are being developed with export-ready infrastructure to serve both domestic and international requirements, reinforcing the state’s position as a major pharmaceutical manufacturing hub. During the financial year, the FDCA issued 330 fresh licences covering new manufacturing units as well as loan licensing arrangements.

The latest approvals indicate sustained demand for pharmaceutical manufacturing capacity and are expected to boost industrial investment, production capabilities, exports and employment across Gujarat.

← All latest storiesBack to top →